Lumida
/AXSM
⌘K
Axsome Therapeutics Inc

Axsome Therapeutics Inc

AXSM
$230.00USD-2.97%-7.04 today

MARKET CAP

11.8B

P/E (TTM)

FWD P/E

148.2x

DAY RANGE

$228 – $237

52W RANGE

$96
$260

AI Summary

Stalk
StalkMedium

AXSM remains in a Stage 2 advancing regime with strong medium- and long-term uptrends, yet recent Bullish Exhaustion and elevated Options Scores signal short-term overextension. Price is extended above the rising 9/20/50 EMA cluster, so execution should be deferred until a shallow pullback into that dynamic support zone. Continued trend integrity and EMA support hold will confirm a favorable entry environment.

  • Q4 2025 revenue surged 65% YoY to $196M, driven by Avelity sales.
  • Avelity generated over $500M in sales since launch, confirming strong market traction.
  • Negative earnings yield and weak book-to-price indicate possible overvaluation.
Full analysis →
Insider Trades24 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jul 1, 2026SellAXSMHerriot TabuteauChief Executive Officer99,332$122.60$11.8B-11.60%+139.36%$12.2M+0.00%10b5-1Stalk
Jun 9, 2026SellAXSMNick PizzieChief Financial Officer66,000$121.80$11.8B-11.60%+139.36%$8.0M+0.00%10b5-1Stalk
Jun 9, 2026SellAXSMHerriot TabuteauChief Executive Officer99,340$122.98$11.8B-11.60%+139.36%$12.2M+0.00%10b5-1Stalk
May 4, 2026SellAXSMMark L. JacobsonChief Operating Officer9,500$120.45$11.8B-11.60%+139.36%$1.1M+0.00%10b5-1Stalk
Apr 22, 2026SellAXSMAri MaizelChief Commercial Officer15,000$126.58$11.8B-11.60%+139.36%$1.9M+0.00%10b5-1Stalk
Feb 26, 2026SellAXSMMark L. JacobsonChief Operating Officer70,756$82.36$11.8B-11.60%+139.36%$5.8M+0.00%10b5-1Stalk
Feb 2, 2026SellAXSMHerriot TabuteauChief Executive Officer64,820$96.81$11.8B-11.60%+139.36%$6.3M+0.00%10b5-1Stalk
Jan 22, 2026SellAXSMNick PizzieChief Financial Officer24,000$95.71$11.8B-11.60%+139.36%$2.3M+0.00%10b5-1Stalk
Jan 21, 2026SellAXSMAri MaizelChief Commercial Officer15,000$127.58$11.8B-11.60%+139.36%$1.9M+0.00%10b5-1Stalk
Jan 5, 2026SellAXSMHerriot TabuteauChief Executive Officer278,828$89.66$11.8B-11.60%+139.36%$25.0M+0.00%10b5-1Stalk
Dec 2, 2025SellAXSMHerriot TabuteauChief Executive Officer159,946$76.84$11.8B-11.60%+139.36%$12.3M+0.00%10b5-1Stalk
Nov 3, 2025SellAXSMHerriot TabuteauChief Executive Officer327,878$70.55$11.8B-11.60%+139.36%$23.1M+0.00%10b5-1Stalk
Oct 6, 2025SellAXSMHerriot TabuteauChief Executive Officer90,768$63.70$11.8B-11.60%+139.36%$5.8M+0.00%10b5-1Stalk
Sep 22, 2025SellAXSMMark L. JacobsonChief Operating Officer20,000$59.41$11.8B-11.60%+139.36%$1.2M+0.00%10b5-1Stalk
Sep 16, 2025SellAXSMMark L. JacobsonChief Operating Officer85,783$63.39$11.8B-11.60%+139.36%$5.4M-8.17%10b5-1Stalk
Sep 12, 2025SellAXSMHerriot TabuteauChief Executive Officer125,760$62.55$11.8B-11.60%+139.36%$7.9M+0.00%10b5-1Stalk
Jun 20, 2025SellAXSMHunter R. MurdockGeneral Counsel27,028$65.67$11.8B-11.60%+139.36%$1.8M+0.00%10b5-1Stalk
Jun 16, 2025SellAXSMHunter R. MurdockGeneral Counsel45,000$65.55$11.8B-11.60%+139.36%$2.9M+0.00%10b5-1Stalk
Jun 9, 2025SellAXSMMark L. JacobsonChief Operating Officer50,000$59.23$11.8B-11.60%+139.36%$3.0M+0.00%10b5-1Stalk
May 27, 2025SellAXSMMark L. JacobsonChief Operating Officer81,346$55.27$11.8B-11.60%+139.36%$4.5M+0.00%10b5-1Stalk
Feb 13, 2025SellAXSMNick PizzieChief Financial Officer30,000$66.80$11.8B-11.60%+139.36%$2.0M+0.00%10b5-1Stalk
Aug 9, 2024SellAXSMMark L. JacobsonChief Operating Officer95,478$44.15$11.8B-11.60%+139.36%$4.2M+0.00%10b5-1Stalk
May 29, 2024BuyAXSMMark L. JacobsonChief Operating Officer21,603$28.03$11.8B-11.60%+139.36%$605.6K+42.23%Stalk
Apr 1, 2024SellAXSMMark L. JacobsonChief Operating Officer49,324$39.27$11.8B-11.60%+139.36%$1.9M+0.00%10b5-1Stalk